中老年男性患者血脂代谢特点及与年龄等因素的相关分析

目的:探讨中老年男性患者血脂代谢特点及与年龄等因素的相关性。方法:资料来自2006年6月于我院干部门诊进行健康查体的1603例中老年男性患者(排除正在服用降脂药物的患者),采用全自动生化分析仪对血清总胆固醇(TC)、血清甘油三酯(TG)、血清低密度脂蛋白胆固醇(LDL-c)、血清高密度脂蛋白胆固醇(HDL-c)、空腹血糖(FBG)、血肌酐(Cr)及血尿酸(UA)等指标进行测定,同时记录身高、体重及血压等基本资料。结果:入选患者血脂异常总检出率为56.27%,其中TC、TG、HDL-c及LDL-c异常检出率分别为36.74%、28.20%、10.79%及6.92%,以TC、TG异常为主。与50~59岁组相比,80岁以上高龄老年组TG异常及HDL-c异常检出率显著降低,TC及TG水平显著降低,HDL-c水平显著升高(P<0.05)。在校正BMI、SBP、DBP、UA、FBG及CCr等危险因素影响后的多元线性回归分析发现,年龄每升高10岁,TC、TG分别降低约0.097 mmol/L及0.087 mmol/L,HDL-c升高约0.113 mmol/L。结论:中老年男性患者血脂异常以高TC和高TG为主,TC、TG与年龄呈负相关,HDL-c与年龄呈正相关,需针对高龄老年患者血脂代谢特点进行合理调脂治疗。     

低密度脂蛋白胆固醇升高在家兔动脉粥样硬化发生发展中的意义

目的观察低密度脂蛋白胆固醇(LDL-c)对家兔动脉粥样硬化(AS)形成的影响,探讨AS的发生机制。方法以高脂饲料复制家兔实验性AS模型,分阶段检测家兔血清胆固醇(TC)、甘油三脂(TG)、高密度脂蛋白胆固醇(HDL-c)和低密度脂蛋白胆固醇(LDL-c)含量;观察主动脉内膜病理学变化;分析主动脉内膜增生程度及AS斑块面积与血浆脂蛋白水平的相关性。结果高脂组家兔主动脉粥样硬化面积和内膜增生程度明显较对照组增加(P<0.01),血浆LDL-c水平明显较对照组升高(P<0.01);动脉内膜增生程度及AS斑块面积均与血浆LDL-c水平呈非常显著正相关(r=0.837,P<0.001)。结论提示血浆LDL-c水平升高,是致AS发生发展的重要原因。     

Effect of Curcuma kwangsiensis polysaccharides on blood lipid profiles and oxidative stress in high-fat rats

We have investigated the protective effect of polysaccharides from Curcuma kwangsiensis (CKP) against oxidative injury in rats fed high-fat diet. The protective effect of CKP was compared with Lovastatin, a well-known antioxidant. Sixty SD rats were used for the experimental study. Oxidative injury was induced by feeding high-fat diet for 3 weeks. The blood profiles, total cholesterol (TC), triacylglycerol (TG), low-density lipoprotein cholesterol (LDL-c) levels during experimental period were significantly increased in untreated model control group, whereas high-density lipoprotein cholesterol (HDL-c) levels and antioxidant enzymes activities significantly decreased in untreated model control group. The levels of TC, TG, LDL-c levels in CKP-treated rats were decreased significantly when compared to the untreated model control group, which were brought down to near normal in CKP-treated group. HDL-c level and antioxidant enzymes activities were found to be significantly increased in serum of CKP-treated group compared to the untreated model control group. The protective effect of CKP against oxidative injury was comparable to that of Lovastatin. Our data suggest that CKP exerts its protective effect by modulating the extent of lipid peroxidation and augmenting antioxidant defense system and thus protects the experimental animals against oxidative injury induced by high-fat diet treatment.     

有氧运动联合破壁蛋白核小球藻对高脂膳食大鼠脂代谢某些指标的影响

目的：研究有氧运动联合破壁蛋白核小球藻对高脂膳食大鼠脂代谢某些指标的影响。方法：55只雄性Wistar大鼠经过适应性饲养4 d后进行3 d、20 min/d的无负重游泳训练,筛选淘汰5只不适应游泳训练的大鼠后,按体重以数字随机分组法分为5组：普通膳食+安静对照组（C组）、高脂膳食+安静对照组（H组）、高脂膳食+小球藻+安静对照组（HC组）、高脂膳食+有氧运动组（HM组）、高脂膳食+有氧运动+小球藻组（HMC）,每组10只。HM组和HMC组进行6周每周6次60 min/d的无负重游泳训练。C组大鼠以普通饲料常规喂养;其余各组以高脂饲料喂养;HC组和HMC组大鼠灌胃破壁小球藻1次,灌胃剂量为3.9 g/（kg·d）,灌胃体积为5 ml/kg,其余各组ig等量生理盐水。6周后,测定大鼠Lee’s指数,取血、肝脏检测相关生化指标。结果：与C组比较,H组Lee’s指数,血清FFA、IL-6、TNF-α、TC、TG、LDL-c,肝脏FFA、IL-10显著升高（P<0.01）;血清HDL-c水平显著降低（P< 0.01）。与H组比较,HC、HM、HMC组Lee’s指数,血清FFA、IL-6、TNF-α、TC、TG、LDL-c,肝脏FFA、IL-10显著降低（P<0.05或P<0.01）;血清HDL-c水平显著升高（P<0.05或P<0.01）。与HC、HM组比较,HMC组Lee’s指数,血清FFA、IL-6、TNF-α、TC、TG、LDL-c,肝脏FFA、IL-10显著降低（P<0.05）;血清HDL-c水平显著升高（P<0.05）。结论：有氧运动和破壁蛋白核小球藻干预能够不同程度改善高脂膳食大鼠脂代谢,降低肥胖对肝脏造成的脂毒性。其中联合干预较单一干预更为有效。     

长爪沙鼠速发型高脂血症模型的初步建立

目的建立长爪沙鼠速发型高脂血症模型的方法。方法用含1%胆固醇高脂饲料分别饲养大鼠、小鼠和沙鼠,检测其血清TC、HDL-c、LDL-c、TG,比较三种动物对饲料反映的特点。结果沙鼠组的TC、HDL-c及LDL-c在第1周时明显的升高,并且平稳的保持此升高趋势到第四周。而TG数值相对平稳,没有变化。而大鼠和小鼠的TC、HDL-c、LDL-c、TG值没有变化。结论通过饲喂高脂饲料可快速诱发长爪沙鼠形成高脂血症模型。     

毛菊苣醇提物对高脂血症性脂肪肝大鼠作用机制初探

目的:目前,国内外研究集中在毛菊苣降糖降脂方面的作用,并已有相关药物上市,但实验表明毛菊苣在保肝降脂作用方面也具有很好的效果,本文旨在探讨毛菊苣醇提物治疗高脂血症性脂肪肝的作用机制。方法:采用高脂饮食喂饲大鼠复制高脂血症性脂肪肝大鼠模型,实验分组为模型组、毛菊苣醇提物治疗高剂量组和低剂量组、苯扎贝特对照组和正常对照组;以高、低剂量毛菊苣醇提物进行干预,然后测定各组大鼠血清及肝组织中乳酸脱氢酶(LDH)、低密度脂蛋白(LDL)、甘油三酯(TG)、胆固醇(TC)、丙二醛(MDA)等指标的含量。结果:模型组大鼠血清及肝组织中LDH、TG、TC、LDL、MDA等活性均较正常组明显升高(P0.05),说明高脂饲料造模成功;与模型组比较,测得各治疗组大鼠血清、肝组织中相应指标均明显降低(P0.05;或P0.1);毛菊苣醇提物高剂量组与阳性对照组相比无显著差异。结论:实验结果表明:通过高脂饮食饲喂SD大鼠建立高脂血症动物模型的实验是成功的;同时,毛菊苣醇提物能够使脂肪肝大鼠的体重降低,降低肝脏脂肪性病变,降低脂肪肝大鼠血清ALT、AST含量,降低大鼠血清TC、TG、LDL-c,升高HDL-c;对模型SD大鼠肝脏中异常升高的MDA、LDH、LD均有明显的降低作用;形态学检查显示,醇提物高剂组肝脏脂变程度明显减轻,脂滴数量减少,提示该药物具有保肝降脂的药理作用。     

非酒精性脂肪性肝病与MTP关系的实验研究

目的：探讨非酒精性脂肪性肝病( Non-alcoholic fatty liver disease, NAFLD)与微粒体甘油三酯转运蛋白(microsomal triglyceridetransfer protein,MTP）的关系。方法：将雄性Wistar 大鼠60只随机分为正常对照组（A 组）、高脂组（B 组）和MTP 抑制剂组（C 组）,每组各20 只。B 组、C组给予高脂饲料喂养,8 周后确认非酒精性脂肪肝建模成功,C组大鼠给予混有特异性小肠MTP抑制 剂JTT-130 的高脂饲料喂养,B 组大鼠建模过程始终喂养高脂饲料,A 组大鼠喂养普通饲料。于第12周,分别测定大鼠血清甘油 三酯(triglyceride,TG)、总胆固醇(total cholesterol,TC)、高密度脂蛋白胆固醇(high density lipoprotein-cholesterol,HDL-c)含量,以及 肝脏TC、TG、磷脂含量。同时测定肝脏中微粒体甘油三酯转运蛋白(MTP) 的活性与mRNA 表达量。结果：与正常对照组（A组）相 比,高脂组（B组）大鼠血清TC、TG、HDL-c 浓度和肝脏TC、TG含量明显提高（P＜0.05）,MTP 活性及mRNA 水平明显下调（P＜ 0.05）。与高脂组（B 组）比较,MTP 抑制剂组（C 组）大鼠血清TC、TG、HDL-c 浓度和肝脏TC、TG 含量明显下降（P＜0.05）,而 MTP 活性及mRNA 表达量比较无明显差别（P＞0.05）。结论：非酒精性脂肪性肝病存在MTP表达下调,特异性小肠MTP 抑制剂 JTT-130 可以有效抑制肠道对TG的转运,不影响肝脏TG分泌,并在降低高脂大鼠血浆TG和胆固醇水平的同时也降低肝脏TG 含量。     

Effect of spermine on lipid profile and HDL functionality in the streptozotocin-induced diabetic rat model

This study aimed to investigate the effect of spermine (Spm) as a chemical chaperone and glycation inhibitor on the lipid profile and HDL functionality in the short- and long-term treatment of the STZ-induced diabetic rats. Male Wistar rats were divided into 4 groups (control, n=7; diabetic, n=9). Two groups (named 2 and 3) were injected intraperitoneally with streptozotocin. Control rats (named 1 and 4) were injected with vehicle alone. The treatment of diabetic and control animals (groups 3 and 4) with 60 micromol/l of Spm in drinking water was begun. The study continued up to the end of the fifth month. The serum glucose and insulin level, AGE formation, lipid profile, paraoxonase 1 (PON1), and lecithin: cholesterol acyl transferase (LCAT) activities were measured. Significantly lower plasma PON1, and LCAT activities and higher serum AGE, TG, TC and LDL-c, and lower HDL-c were seen in diabetic rats as compared to control groups (P<0.01). The increased AGE, TG, TC and LDL-c levels in diabetic groups decreased gradually after receiving Spm. In addition, due to Spm administration, an increase in the HDL-c level was observed after the first month of the experiment (P<0.01). The increase in the PON1 and LCAT activities in the diabetic group that received Spm was significant after the second and the forth month of the experiment, P<0.02 and P<0.05, respectively. In conclusion, spermine administration attenuated the changed parameters to near normal values in diabetic rats. Spermine, despite a lack of significant changes on glucose metabolism and insulin secretion, was found to improve diabetes complications.     

The antihypercholesterolemic effect of jatrorrhizine isolated from Rhizoma Coptidis

Current work was conducted to evaluate the safety and antihypercholesterolemic activity of jatrorrhizine extracted from Rhizoma Coptidis (RC) and its potential mechanism on regulating cholesterol metabolism. It was found that the LD₅₀ of jatrorrhizine in mice was more than 5500 mg/kg and there were no influences on clinical signs, organ weight changes, urinalysis and hematological parameters, gross necropsy and histological alterations in jatrorrhizine-treated rats during the 3-month period, compared to the control group. Jatrorrhizine showed a strong lipid-lowering effect in a dose-dependent manner. Oral administration of 70.05 mg/kg of jatrorrhizine on Mesocricetus auratus (Syrian golden hamsters) exhibited significant decrease in TC, TG, and LDL-c levels by 20%, 43%, and 19%, respectively, and increase in HDL-c and total bile acids (TBA) content in feces (p < 0.01), compared to high-fat and high-cholesterol (HFHC) group. Besides, jatrorrhizine dose-dependently slowed the rate of weight gain. The results of qRT-PCR, western blotting and ELISA revealed that jatrorrhizine significantly up-regulated the mRNA and protein expression of LDLR and CYP7A1, but exhibited no significant effect on mRNA and protein expression of HMGR and ASBT in hamsters.In conclusion, jatrorrhizine was a safe and potential antihypercholesterolemic agent from RC which could improve the utilization and excretion of cholesterol by up-regulating the mRNA and protein expression of LDLR and CYP7A1.     

Perfil lipídico en mujeres obesas y no obesas con síndrome de ovarios poliquísticos tratadas con metformina

ObjectiveTo compare lipid and lipoprotein concentrations between obese and non-obese women with a diagnosis of polycystic ovary syndrome (PCOS) treated with metformin for 6 months.MethodsSixty-five women with a diagnosis of PCOS were included. The presence of obesity, serum concentrations of cholesterol, triglycerides, high-density lipoprotein cholesterol (HDL-c) and low-density lipoprotein cholesterol (LDL-c) were recorded before and after 6 months of metformin treatment. The women were divided in two groups of 34 obese women (group A; body mass index >27 kg/m²) and 31 non-obese women (group B; body mass index (<27 kg/m²).ResultsSignificant differences in body mass index, waist-hip ratio, cholesterol, triglycerides, LDL-c and HDL-c were found in group A compared with group B (p<0.05). In obese women, serum triglyceride and LDL-c concentrations were significantly reduced (p<0.05), while serum concentrations of HDL-c were significantly increased (p<0.05) after 6 months of treatment. In non-obese women, none of these lipid profile modifications were considered significant (p=ns).ConclusionMetformin use for 6 months modified triglyceride, LDL-c and HDL-c concentrations compared with initial values in obese women with PCOS while no significant modifications in lipid or lipoprotein concentrations were observed in non-obese women.     

循环内皮微粒相关microRNA在巨噬细胞炎性反应诱发动脉粥样硬化发生中的作用机制

目的研究循环内皮微粒相关microRNA在巨噬细胞炎性反应诱发动脉粥样硬化（AS）发生的作用机制。 方法选取实验组和对照组SPF级5周小鼠各50只。实验小鼠分4组：对照组、动脉粥样硬化模型组（AS模型组）、NC-miRNA组和miRNA-19b抑制剂组,采用油红染色对AS病变的组织学进行观察,计算斑块面积相对比例,并检测生化指标的表达水平,主要包括血清中高密度脂蛋白胆固醇（HDL-C）、胆固醇（TC）、低密度脂蛋白胆固醇（LDL-C）和甘油三酯（TG）,ELISA检测血管炎症因子TNF-α、IL-1、IL-6和IL-10的变化,Western Blot检测凋亡相关蛋白Bcl-2、cleaved-caspase-3和Bax表达的变化,实时荧光定量PCR检测miR-19b表达,流式细胞法检测巨噬细胞的凋亡率。多组间比较采用单因素方差分析或者重复测量的方差分析,两两比较采用LSD-t检验。 结果各组胸腔动脉斑块面积百分比：对照组为（0.00±0.00）%;AS模型组为（9.59±6.53）%;NC-miRNA组为（8.96±3.47）%;miRNA-19b抑制剂组为（3.21±2.03）%,三组间比较差异有统计学意义（F = 20.572,P = 0.002）。与对照组比较,AS模型组和NC-miRNA组TC[AS模型组（3.26±0.21）mmol/L;NC-miRNA组（3.13± 0.14）mmol/ L;F = 13.994,P = 0.002]、TG[AS模型组（0.25±0.06）mmol/L;NC- miRNA（0.21±0.02）mmol/L;F = 11.230,P = 0.011）]和LDL-C [AS模型组（1.65±0.11）mmol/ L;NC-miRNA （1.59± 0.27）mmol/L;F = 10.069,P = 0.006）]水平升高,而HDL-CAS模型组[（0.08±0.09）mmol/L;NC-miRNA （0.08±0.05）mmol/L;F = 12.450,P = 0.004）]水平含量降低。与模型组比较,miRNA-19b抑制剂组TC（1.85±0.06）mmol/L、TG（0.15±0.03）mmol/ L和LDL-C（1.21±0.10）mmol/L水平降低,HDL-C （0.11±0.05）mmol/L水平则升高（P均< 0.05）。AS模型组与对照组相比,IL-1（34.06±3.58）g/L、IL-6（92.57±31.97）g/L和TNF-α（63.01±15.65）g/L水平升高,而IL-10（16.86±1.29）g/L的水平降低,NC-miRNA组各指标亦有相同的变化趋势;miRNA-19b抑制剂组IL-1（24.85±6.21）g/L、IL-6（53.29±17.15）g/ L和TNF-α（34.51±6.47 ）g/L水平低于AS模型组和NC-miRNA组（F = 13.671,P = 0.002）,IL-10（24.94±4.72）g/L的水平则高于两组（F = 13.675,P = 0.008）。和对照组相比,AS模型组和NC- miRNA组的Bax（AS模型组3.39±0.01;NC-miRNA组0.64±0.02;F = 26.910,P = 0.000）和cleaved-PARP （AS模型组2.47±0.05;NC- miRNA组3.27±0.01;F = 13.226,P = 0.000）表达量升高。但Bcl-2（AS模型组0.67±0.02;NC-miRNA组0.64±0.02;F = 12.585,P = 0.000）表达水平下调。与NC- miRNA组相比,miRNA-19b抑制剂组的促细胞凋亡的蛋白Bax（2.16±0.02）和cleaved-PARP（1.91±0.04）表达水平下调,Bcl-2（1.05±0.01）的表达水平上调。与对照组比较,AS模型组（2.71±0.02）和NC-miRNA组（2.43±0.02）的miRNA- 19b的转录水平增加,差异有统计学意义（P均< 0.05）,miRNA-19b抑制剂组（1.52±0.01）转录水平有升高,但相较于AS模型组和NC-miRNA组的变化其增加量不显著,（F = 15.353,P = 0.002）。miRNA-19b基因转录水平：对照组为1.02±0.03;AS模型组为2.71±0.02;NC- miRNA组为2.43±0.02;miRNA- 19b抑制剂组为1.52±0.01（P均 < 0.05）。细胞凋亡率：对照组为（4.41±0.18）%;AS模型组为（7.16±0.73）%;NC-miRNA组为（6.29±0.24）%;miRNA-19b抑制剂组为（5.01±0.11）%,（F = 12.889,P = 0.008）。 结论miRNA-19b抑制剂可以减少巨噬细胞的凋亡,降低促炎症因子,可减少由于AS引起的血管厚度的增加,减少AS斑块的面积比例,使血脂中的TC、TG和LDL-C水平降低,HDL-C水平则有升高,这对冠心病的临床诊疗具有重要的临床指导意义。     

紫檀芪调节Keap-1/Nrf2/HO-1信号通路对非酒精性脂肪肝大鼠氧化应激和细胞凋亡的影响

摘要 目的：研究紫檀芪调节Kelch样ECH关联蛋白1（Keap-1）/核因子E2相关因子2（Nrf2）/血红素加氧酶-1（HO-1）信号通路对非酒精性脂肪肝（NAFLD）大鼠氧化应激和细胞凋亡的影响。方法：将60只SD大鼠随机分为对照组、模型组、紫檀芪低剂量组（30 mg/kg）、紫檀芪高剂量组（60 mg/kg）、紫檀芪（60 mg/kg）+N-（4-（2,3-二氢-1-（2''-甲基苯甲酰）-1H-吲哚-5-基）-5-甲基-2-噻唑基）-1,3-苯并二氧唑-5-乙酰胺（ML385）（30 mg/kg）组，每组12只。模型组与药物干预组大鼠以高脂饲料饲养诱导NAFLD模型，对照组大鼠以普通饲料饲养，各组连续喂养12周。以紫檀芪和ML385分组处理14 d后（对照组以等剂量生理盐水处理），检测各组大鼠脂代谢指标[三酰甘油（TG）、总胆固醇（TC）及游离脂肪酸（FFA）水平]、肝指数、肝功能指标[谷丙转氨酶（ALT）及谷草转氨酶（AST）]水平、血清白细胞介素（IL）-17、IL-6、IL-10、氧化应激指标[丙二醛（MDA）、超氧化物歧化酶（SOD）及过氧化氢酶（CAT）]水平；原位末端标记法（TUNEL）染色检测各组大鼠肝细胞凋亡率；蛋白免疫印迹法检测各组大鼠肝组织凋亡相关蛋白及Keap-1/Nrf2/HO-1通路相关蛋白表达。结果：与对照组相比，模型组大鼠血清IL-10、SOD及CAT水平、肝组织Nrf2、HO-1、Bcl-2表达水平显著降低（P＜0.05），TG、TC及FFA水平、肝指数、ALT及AST水平、血清IL-17、IL-6、MDA水平、肝细胞凋亡率、肝组织Keap-1及Bax表达水平显著升高（P＜0.05）。与模型组相比，紫檀芪低、高剂量组大鼠血清IL-10、SOD及CAT水平、肝组织Nrf2、HO-1、Bcl-2表达水平均升高（P＜0.05），TG、TC及FFA水平、肝指数、ALT及AST水平、血清IL-17、IL-6、MDA水平、肝细胞凋亡率、肝组织Keap-1、Bax表达水平均降低（P＜0.05）；与紫檀芪低剂量组相比，紫檀芪高剂量组大鼠血清IL-10、SOD及CAT水平、肝组织Nrf2、HO-1、Bcl-2表达水平升高（P＜0.05），TG、TC及FFA水平、肝指数、ALT及AST水平、血清IL-17、IL-6、MDA水平、肝细胞凋亡率、肝组织Keap-1及Bax表达水平降低（P＜0.05）；与紫檀芪高剂量组相比，紫檀芪+ML385组大鼠血清IL-10、SOD及CAT水平、肝组织Nrf2、HO-1、Bcl-2表达水平降低（P＜0.05），TG、TC及FFA水平、肝指数、ALT及AST水平、血清IL-17、IL-6、MDA水平、肝细胞凋亡率、肝组织Bax表达水平升高（P＜0.05）。结论：紫檀芪可能通过激活Keap-1/Nrf2/HO-1信号通路，改善NAFLD大鼠脂代谢水平，调节炎症反应及氧化应激，减轻肝组织脂肪变性及细胞凋亡。     

The timing of re-institution of good blood glucose control affects apoptosis and expression of Bax and Bcl-2 in the retina of diabetic rats

Hyperglycemia initiates a sequence of events that leads to the development of diabetic retinopathy. We explored the effect of re-institution of good blood glucose control on apoptosis and apoptosis related genes (Bax and Bcl-2) in the retina of diabetic rats. Fifty male Wistar rats randomly divided into five groups : normal control group (CON), diabetic rats with high blood glucose levels for 8 months group (DM) ,diabetic rats with good blood glucose control for 8 months group (DM₁),diabetic rats with poor blood glucose control for 2 month followed by good blood glucose control for six additional months group (DM₂), rats with poor blood glucose control for 4 months followed by good blood glucose levels for four additional months group (DM₃). Expression of Bax and Bcl-2 in the retina was studied by immunohistochemistry and the apoptotic cells were stained using the TUNEL method. The apoptotic cell, expression of Bax and Bcl-2 and the ratio of Bax to Bcl-2 in the retina was increased in DM group compared with normal rats’ (P < 0.01). There was no significant difference in apoptotic cells and the ratio of Bax to Bcl-2 between DM₁ group and CON group. The number of TUNEL positive cells and Bax to Bcl-2 ratio was partially reversed in DM₂ group. But glucose control had no effect on the apoptotic cells and the expression of Bax and Bcl-2 in DM₃ group. There was a positive correlation between apoptotic cells and Bax/Bcl-2 ratio in the retina (r = 0.808, P < 0.01). Good blood glucose control at early stage can decrease the number of apoptotic cells in the retina; the decreased apoptosis is correlated with the down-regulation of Bax to Bcl-2 ratio.     

16周有氧运动对中老年baPWV及ABI的影响

目的：探讨16周有氧运动锻炼对中老年动脉硬化的干预作用及相关机制。方法：以27名中老年人为研究对象,平均年龄（62.70 ±3.26）岁,采用每次60 min、每周6次,共16周的广场舞/太极拳进行锻炼,分别测试锻炼前和锻炼8周末、16周末受试者收缩压（SBP）、舒张压（DBP）、左肱踝动脉脉搏波传导速度（L-baPWV）、右肱踝动脉脉搏波传导速度（R-baPWV）、左踝臂血压指数（L-ABI）和右踝臂血压指数（R-ABI）的变化,并检测血清甘油三酯（TG）、总胆固醇（TC）、高密度脂蛋白胆固醇（HDL-c）、低密度脂蛋白胆固醇（LDL-c）、超氧化物歧化酶（SOD）、丙二醛（MDA）和谷胱甘肽过氧化物酶（GSH-Px）等相关指标的变化。结果：①与运动前相比,有氧运动锻炼8周末R-baPWV、R-ABI下降,16周末则L-baPWV、R-baPWV、R-ABI、L-ABI均呈显著性下降（P<0.01）;②与运动前比,8周末SBP和DBP显著下降（P<0.05）,16周末SBP、DBP和脉压差则显著降低（P<0.01,P<0.05）;③与运动前相比,在8周末、16周末受试者TC、LDL-c均显著降低（P<0.01）,HDL-c、TG在8周末和16周末的变化则无统计学意义;④与试验前相比,8周末血清SOD、GSH-Px、MDA无明显变化,16周末血清SOD、GSH-Px活性呈显著性升高、而血清MDA含量则呈显著性下降（P<0.01）。结论：通过16周有氧运动,可明显降低中老年人baPWV和ABI水平,调节血压、血脂及过氧化脂质水平,进而可能对动脉硬化程度起到一定的改善作用。     

Immediate effect of fluvastatin on lipid levels in acute coronary syndrome

It is widely assumed that acute benefit of statin therapy is mediated especially by non-lipid effects. The immediate influence of statins on lipid levels in patients with acute coronary syndrome (ACS) is, however, not clear. A total of 64 consecutive patients with ACS were randomized at admission to fluvastatin 80 mg (Group 1, N = 32) or standard therapy without statin (Group 2, N = 32). The levels of total cholesterol (TC), low-density-lipoprotein cholesterol (LDL-C), high-density-lipoprotein cholesterol (HDL-C), and triglycerides (TG) were examined at admission and after 24 h. Baseline characteristics were comparable in both groups. In Group 1, fluvastatin significantly decreased the levels of TC by 14.5%, LDL-C by 17.2%, and HDL-C by 10.0% (P < 0.001); TG were not influenced. In Group 2 only marginal reductions in TC (by 4.1%, P = 0.03) and HDL-C (by 7.5%, P < 0.01) were detected; the levels of LDL-C and TG were not changed. As compared with Group 2, in Group 1 the final levels of TC (P = 0.02) and LDL-C (P = 0.01) were significantly lower. Fluvastatin therapy, when started at admission in patients with ACS, significantly reduces TC and LDL-C already after 24 h. We suggest that the lipid-lowering effect of statins in the therapy of ACS is probably as prompt as non-lipid effects.     

格列齐特对糖尿病大鼠心肌的保护作用及其机制*

目的: 观察格列齐特对糖尿病大鼠心肌保护作用及其可能的机制。方法: 将60只健康SD大鼠随机分为正常组(NC,n=10),造模组(n=50)给予高糖高脂饲料4周后,腹腔注射STZ(45 mg/kg)建立糖尿病大鼠模型,随机抽取以FBG≥16.7 mmol/L作为糖尿病模型建立成功。将造模成功的38只糖尿病大鼠随机分为模型组(MC,n=9)、格列齐特组(Glic,80 mg/kg,n=10)、格列本脲组(Glib,2.5 mg/kg,n=10)、法舒地尔组(Fas,10 mg/kg,n=9);NC组和MC组灌胃等容积蒸馏水,Glic组和Glib组灌胃给药,Fas组采用腹腔注射。各组大鼠每天给药一次,每周记录体质量及空腹血糖(FBG),持续8周。实验结束时取血并测定心脏质量,计算心脏质量指数(HWI);测定各组糖化血红蛋白(HbA1c)、总胆固醇(TC)、甘油三酯(TG)、高密度脂蛋白(HDL-C)、低密度脂蛋白(LDL-C)含量以及血清丙二醛(MDA)水平和超氧化物歧化酶(SOD)活性;通过HE和Masson染色,观察心肌病理变化和组织胶原纤维水平;TUNEL染色观察并计算心肌细胞凋亡率;Western blot法检测心肌组织中RhoA、ROCK1、eNOS、Bcl-2和Bax蛋白表达。结果: 与NC组比较,MC组FBG、HWI、HbA1c、TC、TG、LDL-C、MDA水平,心肌组织胶原沉积和心肌细胞凋亡率以及心肌组织中RhoA、ROCK1、Bax蛋白明显升高,SOD活性及HDL-C、eNOS、Bcl-2和体重显著降低(P＜0.01);与MC组相比,Glic组FBG、HWI、HbA1c、TC、TG、LDL-C和MDA等指标明显下降,心肌组织胶原沉积及心肌细胞凋亡减轻,心肌组织RhoA、ROCK1、Bax蛋白表达下调(P＜0.01或P＜0.05),大鼠体重和血清中SOD活性,HDL-C升高,eNOS、Bcl-2蛋白水平升高(P＜0.01或P＜0.05)。与Glic组相比,Glib组与Fas组体重、血脂、FBG、HWI、MDA以及心肌纤维化和心肌细胞凋亡水平升高,SOD和Bcl-2降低,Glib组心肌组织RhoA、ROCK1、Bax蛋白表达上调(P＜0.01或P＜0.05)。结论: 格列齐特可改善糖尿病大鼠心肌损伤并减轻心肌细胞凋亡水平,其机制可能与降低血糖,改善氧化应激状态,调控RhoA/ROCK1/eNOS信号通路有关。     

共轭亚油酸降血脂及抗动脉粥样硬化作用的研究

目的:探讨共轭亚油酸降血脂及抗动脉粥样硬化形成的作用机制。方法:选用大鼠随机分为正常对照组,高脂模型组,c9,t11CLA:t10,c12CLA=2:1、1:1、1:3、1:6,只含t10,c12CLA共7组。实验至第8周末取血,检测血清胆固醇(TC)、三酰甘油(TG)、高密度脂蛋白(HDL)、低密度脂蛋白(LDL)和丙二醛(MDA)、超氧化物歧化酶(SOD)活性。结果:与高脂模型组比较,共轭亚油酸组大鼠血清TC、TG、MDA含量明显降低,HDL、SOD含量明显提高(P<0.05)。结论:共轭亚油酸具有降低血脂和抗动脉粥样硬化的作用。     

有氧运动对非酒精性脂肪肝小鼠肝脏CNPY2-PERK通路的影响

目的:探讨有氧运动对高脂诱导小鼠非酒精性脂肪肝(NAFLD)的影响及其肝脏冠层成纤维细胞生长因子信号调节器2 (CNPY2)-PKR样内质网激酶(PERK)机制。方法:8周龄雄性C57BL/6J小鼠随机分为对照组(C)、对照+运动组(CE),NAFLD模型组(M)和NAFLD模型+运动组(ME),每组10只。C组和CE组小鼠给予普通饲料,M组和ME组小鼠给予高脂饲料(脂肪供能占比为60%),连续喂养18周至实验结束,取小鼠血清和肝脏。CE组和ME组从第10周起进行有氧跑台训练(12 m/min,每次60 min,每周5 d)。检测小鼠血清总胆固醇(TC)、总甘油三酯(TG)、高密度脂蛋白胆固醇(HDL-c)、低密度脂蛋白胆固醇(LDL-c)、丙氨酸氨基转移酶(ALT)和天冬氨酸转氨酶(AST)水平;观察小鼠肝组织病理学形态;检测肝组织CNPY2、PERK、p-eIF2a、CHOP、CNPY2 mRNA、PERK mRNA表达和CNPY2、PERK的阳性表达。结果:与C组比较,M组小鼠的血清LDL-c、TC、TG、ALT和AST水平显著升高(P<0.05),HDL-c水平显著降低(...